Christina I Deligianni (Christina Deligianni)

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 15

Top Topics

Extracorporeal Membrane Oxygenation

Respiratory Failure

Neuropathic Pain

Respiratory Syndrome Coronavirus

Top Venues

European journal of neurology

Journal of medical economics

The journal of headache and pain

Journal of comparative effectiveness research

This page only lists publications with an associated author ORCID identifier.

Publications

Dimos-Dimitrios D Mitsikostas, Edoardo Caronna, Marina de Tommaso, Christina I Deligianni, Esme Ekizoğlu, Hayrunnisa Bolay Belen, Carl H Göbel, Espen Saxhaug Kristoffersen, Christian Lampl, Elena F Moro, Patricia Pozo-Rosich, Johann Sellner, Gisela M Terwindt, Pablo Irimia Sieira
Headaches and facial pain attributed to SARS-CoV-2 infection and vaccination: a systematic review. European journal of neurology (2024)
Dimos-Dimitrios D Mitsikostas, Edoardo Caronna, Marina de Tommaso, Christina I Deligianni, Esme Ekizoğlu, Hayrunnisa Bolay Belen, Carl H Göbel, Espen Saxhaug Kristoffersen, Christian Lampl, Elena F Moro, Patricia Pozo-Rosich, Johann Sellner, Gisela M Terwindt, Pablo Irimia Sieira
Headaches and facial pain attributed to SARS-CoV-2 infection and vaccination: a systematic review. European journal of neurology 31 (6) (2024)
Dimos-Dimitrios D Mitsikostas, Edoardo Caronna, Marina de Tommaso, Christina I Deligianni, Esme Ekizoğlu, Hayrunnisa Bolay Belen, Carl H Göbel, Espen Saxhaug Kristoffersen, Christian Lampl, Elena Moro, Patricia Pozo-Rosich, Johann Sellner, Gisela M Terwindt, Pablo Irimia Sieira
Reply to the letter: Headaches during/after SARS-CoV-2 infection/vaccination can be primary and secondary as well as acute and chronic, by Finsterer J and Mehri S. European journal of neurology (2024)
Christina I Deligianni, Paolo Martelletti, Dimos-Dimitrios D Mitsikostas
Placebo responses vary by route of administration in migraine prevention trials. What does this mean? Journal of medical economics 27 (1) (2024)
Christina I Deligianni, Paolo Martelletti, Dimos-Dimitrios D Mitsikostas
Placebo responses vary by route of administration in migraine prevention trials. What does this mean? Journal of medical economics 27 (1) (2024)
Dimos-Dimitrios D Mitsikostas, Edoardo Caronna, Marina de Tommaso, Christina I Deligianni, Esme Ekizoğlu, Hayrunnisa Bolay Belen, Carl H Göbel, Espen Saxhaug Kristoffersen, Christian Lampl, Elena F Moro, Patricia Pozo-Rosich, Johann Sellner, Gisela M Terwindt, Pablo Irimia Sieira
Headaches and facial pain attributed to SARS-CoV-2 infection and vaccination: a systematic review. European journal of neurology 31 (6) (2024)
Christina I Deligianni, Paolo Martelletti, Dimos-Dimitrios D Mitsikostas
Placebo responses vary by route of administration in migraine prevention trials. What does this mean? Journal of medical economics 27 (1) (2024)
Dimos-Dimitrios D Mitsikostas, Edoardo Caronna, Marina de Tommaso, Christina I Deligianni, Esme Ekizoğlu, Hayrunnisa Bolay Belen, Carl H Göbel, Espen Saxhaug Kristoffersen, Christian Lampl, Elena Moro, Patricia Pozo-Rosich, Johann Sellner, Gisela M Terwindt, Pablo Irimia Sieira
Reply to the letter: Headaches during/after SARS-CoV-2 infection/vaccination can be primary and secondary as well as acute and chronic, by Finsterer J and Mehri S. European journal of neurology 31 (7) (2024)
Dimos-Dimitrios D Mitsikostas, Edoardo Caronna, Marina de Tommaso, Christina I Deligianni, Esme Ekizoğlu, Hayrunnisa Bolay Belen, Carl H Göbel, Espen Saxhaug Kristoffersen, Christian Lampl, Elena F Moro, Patricia Pozo-Rosich, Johann Sellner, Gisela M Terwindt, Pablo Irimia Sieira
Headaches and facial pain attributed to SARS-CoV-2 infection and vaccination: a systematic review. European journal of neurology (2024)
Dimos-Dimitrios D Mitsikostas, Edoardo Caronna, Marina de Tommaso, Christina I Deligianni, Esme Ekizoğlu, Hayrunnisa Bolay Belen, Carl H Göbel, Espen Saxhaug Kristoffersen, Christian Lampl, Elena Moro, Patricia Pozo-Rosich, Johann Sellner, Gisela M Terwindt, Pablo Irimia Sieira
Reply to the letter: Headaches during/after SARS-CoV-2 infection/vaccination can be primary and secondary as well as acute and chronic, by Finsterer J and Mehri S. European journal of neurology 31 (7) (2024)
Christina I Deligianni, Paolo Martelletti, Dimos-Dimitrios D Mitsikostas
Placebo responses vary by route of administration in migraine prevention trials. What does this mean? Journal of medical economics (2024)
Dimos-Dimitrios D Mitsikostas, Edoardo Caronna, Marina de Tommaso, Christina I Deligianni, Esme Ekizoğlu, Hayrunnisa Bolay Belen, Carl H Göbel, Espen Saxhaug Kristoffersen, Christian Lampl, Elena F Moro, Patricia Pozo-Rosich, Johann Sellner, Gisela M Terwindt, Pablo Irimia Sieira
Headaches and facial pain attributed to SARS-CoV-2 infection and vaccination: a systematic review. European journal of neurology 31 (6) (2024)
Dimos-Dimitrios D Mitsikostas, Edoardo Caronna, Marina de Tommaso, Christina I Deligianni, Esme Ekizoğlu, Hayrunnisa Bolay Belen, Carl H Göbel, Espen Saxhaug Kristoffersen, Christian Lampl, Elena Moro, Patricia Pozo-Rosich, Johann Sellner, Gisela M Terwindt, Pablo Irimia Sieira
Reply to the letter: Headaches during/after SARS-CoV-2 infection/vaccination can be primary and secondary as well as acute and chronic, by Finsterer J and Mehri S. European journal of neurology 31 (7) (2024)
Christina I Deligianni, Paolo Martelletti, Dimos-Dimitrios D Mitsikostas
Are indirect comparisons for treatments in migraine necessitas? Many inevitable challenges to overcome. Journal of comparative effectiveness research (2023)
Simona Sacco, Christian Lampl, Faisal Mohammad Amin, Mark Braschinsky, Christina I Deligianni, Derya Uludüz, Jan Versijpt, Anne Ducros, Raquel Gil-Gouveia, Zaza Katsarava, Paolo Martelletti, Raffaele Ornello, Bianca Raffaelli, Deirdre M Boucherie, Patricia Pozo-Rosich, Margarita Sanchez Del Rio, Alexandra Jean Sinclair, Antoinette MaassenVanDenBrink, Uwe Reuter
European Headache Federation (EHF) consensus on the definition of effective treatment of a migraine attack and of triptan failure. The journal of headache and pain 23 (1) (2022)